000			01721 a2200445 4500
005			20250513235126.0
264		0	_c20010517
008			200105s 0 0 eng d
022			_a0026-895X
024	7		_a10.1124/mol.59.5.1256 _2doi
040			_aNLM _beng _cNLM
100	1		_aRoseberry, A G
245	0	0	_aAgonist-dependent delivery of M(2) muscarinic acetylcholine receptors to the cell surface after pertussis toxin treatment. _h[electronic resource]
260			_bMolecular pharmacology _cMay 2001
300			_a1256-68 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aBiological Transport _xdrug effects
650	0	4	_aBrefeldin A _xpharmacology
650	0	4	_aCells, Cultured
650	0	4	_aDrug Interactions
650	0	4	_aGTP-Binding Protein alpha Subunits, Gi-Go _xmetabolism
650	0	4	_aGTP-Binding Proteins _xmetabolism
650	0	4	_aGolgi Apparatus _xmetabolism
650	0	4	_aHeterotrimeric GTP-Binding Proteins _xmetabolism
650	0	4	_aHumans
650	0	4	_aMuscarinic Agonists _xpharmacology
650	0	4	_aPertussis Toxin
650	0	4	_aPhosphorylation _xdrug effects
650	0	4	_aProtein Synthesis Inhibitors _xpharmacology
650	0	4	_aProtein Transport _xdrug effects
650	0	4	_aReceptor, Muscarinic M2
650	0	4	_aReceptors, Cell Surface _xmetabolism
650	0	4	_aReceptors, Muscarinic _xmetabolism
650	0	4	_aVirulence Factors, Bordetella _xpharmacology
700	1		_aBünemann, M
700	1		_aElavunkal, J
700	1		_aHosey, M M
773	0		_tMolecular pharmacology _gvol. 59 _gno. 5 _gp. 1256-68
856	4	0	_uhttps://doi.org/10.1124/mol.59.5.1256 _zAvailable from publisher's website
999			_c11241465 _d11241465